1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsVagelos Precision Medicine Pilot Grant is sponsored by Columbia Precision Medicine Initiative. This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
The Vagelos Precision Medicine Pilot Grant program is made possible by the generous gift of Roy and Diana Vagelos, to the Columbia Precision Medicine Initiative, and is intended to support ground-breaking research in the field of precision medicine. Proposals are requested for two-year pilot studies in precision medicine. Awardees will receive $100,000 per year for two years.
Studies must be relevant to advancing precision medicine basic science. Examples areas include genomic data, biomarkers, clinical data, new methods of working with precision medicine data, technology development, disease mechanism studies and stem cell biology. For research with human subjects, an IRB must be in place at the time of funding.
These pilot grants are intended to support feasibility studies that will establish a basis for applying for further research funding. As such, pilot grants are intended to generate preliminary data required to produce competitive grant applications to outside funders. Three studies will be funded, with additional calls for proposals expected next year.
**Eligibility****:** Applicants must have a full-time Columbia University faculty appointment at the rank of an Assistant, Associate, or Full Professor, including NYPSI and clinical faculty. Studies may involve more than one department, including collaboration between Morningside and Medical Center campuses. Preference will be given to applications including junior investigators.
Applicants may apply for the Irving Institute Precision Medicine award and the Vagelos award, but may not hold both concurrently; if successful in both applicants will be able to choose their preferred award. **Budget****:**$100,000 per fiscal year for two years.
Second year funding contingent on satisfactory progress report **Application Directions****:**Prepare detailed project description (2-4 page excluding references, minimum 11-point font) as follows: • Background and Specific Aims • Future Plans and Direction Provide the following supporting documents: • Statement of Facilities and other Resources • NIH-style biographical sketch for each investigator (5-page limit) **Submit documents by December 11th 2017, preferably as one single pdf to precisionmedicine@columbia.
edu** Questions? Email **precisionmedicine@columbia. edu**
According to the current listing, eligibility includes: Applicants must have a full-time Columbia University faculty appointment at the rank of an Assistant, Associate, or Full Professor, including NYPSI and clinical faculty. Confirm the full requirements in the official notice before applying.
The current listing shows $100,000 per year for two years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Vagelos Precision Medicine Pilot Grant is funded by Columbia Precision Medicine Initiative. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleARPA-H launched SPECTRA on September 17, 2026 under solicitation ARPA-H-SOL-26-163 — four technical areas with separate Solution Summary deadlines on October 18, December 2, and January 18. The enabling-technologies area closes first, five weeks after launch. Here is why the sequencing matters and how to read each TA.
Read articleDARPA pre-released Release 6 of its FY26 SBIR BAA on September 2, 2026. Five of the seven SBIR topics belong to the Biological Technologies Office, and four of those describe one continuous problem: keeping a casualty alive with no surgeon, no imaging, and no evacuation. Here are the award sizes, the Direct-to-Phase-II gates, and the sequencing DARPA is buying.
Read article